Cite
HARVARD Citation
Awan, F. et al. (2019). Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study. Leukemia & lymphoma. 60 (8), pp. 1972-1977. [Online].